Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
All APAC Global
All APAC Global
All APAC Global
All APAC Global
New Data for BAVENCIO® (avelumab) for Advanced Cancers to Be Presented at ESMO 2019 2019-09-27 14:00
New Clarivate Analytics report shows the cost to bring a drug to market has decreased to under $2B for the first time in over five years 2019-09-26 21:00
Thermo Fisher Scientific Expands Clinical Trials Capabilities and Announces Collaboration with Frontier Biotechnologies Inc. 2019-09-26 14:00
OrbusNeich® Announces Japan Approval for COMBO® Plus Coronary Stent 2019-09-26 01:01
Helsinn and Mundipharma China Pharmaceutical jointly announce NMPA's approval of the oral formulation of Akynzeo(R) in China 2019-09-25 12:11
Supply Chain Digitization Creates New Revenue Opportunities in the Vaccine Market 2019-09-24 23:28
Global Pharmaceutical Functional and Multifunctional Excipients Industry to Cross the $10 Billion Mark by 2023 2019-09-24 22:45
PolyU develops a new class of antibiotic candidates for fighting against superbugs 2019-09-24 17:46
CPhI recruiting freelance pharmaceutical authors contributing to the global industry professionals 2019-09-23 17:56
New Data at ESMO 2019 for Merck Highlight Focused Clinical Development and Commitment to Patient Care 2019-09-23 14:00
2019 CSCO| CStone announces promising ORR, anti-tumor activity and safety data with its anti-PD-L1 antibody CS1001 in MSI-H/dMMR solid tumors 2019-09-22 14:22
2019 CSCO | CStone announces preliminary results from Phase I trial of CS1002 demonstrating characteristics comparable to ipilimumab 2019-09-22 13:39
2019 CSCO | CStone releases preliminary results from the Phase Ia trial of CS1003 in Chinese patients with advanced tumors 2019-09-21 00:26
CHMP Adopts Positive Opinion for BAVENCIO® (avelumab) Plus Axitinib for First-Line Treatment of Patients with Advanced Renal Cell Carcinoma 2019-09-20 20:34
Innovent Provides Update on Two Studies of IBI301 (Rituximab Biosimilar) in the Treatment of CD20-positive Lymphoma at Annual Meeting of CSCO 2019-09-20 14:30
2019 CSCO | CStone announces promising trial data on its anti-PD-L1 antibody in esophageal squamous cell carcinoma with an ORR of 77.8% 2019-09-19 23:48
Advanced Aesthetic Technologies and China National Biotec Group Announce Strategic Cooperation 2019-09-19 23:12
Tresiba® Showed an Overall Lower Risk of Hypoglycaemia and Significantly Lower HbA1c When Compared to Insulin Glargine U300 in People With Type 2 Diabetes 2019-09-19 18:01
Innovent Provides Update on the Results of IBI305 for the First-line Treatment of Advanced Non-squamous Cell Lung Cancer by Oral Presentation at CSCO 2019-09-19 16:36
Inovio Receives NIH Funding to Target its dMAb® Technology Against Antimicrobial-Resistant Infection 2019-09-17 21:00
1 189 190 191 192 193 246